Appointments
HMNC Brain Health, a clinical-stage biopharma company pioneering the development of personalised therapies powered by predictive companion...
Amphista Therapeutics have appointed Beverley Carr Chief Business Officer. Amphista is a leader in next generation targeted protein degradation (...
Mogrify Limited have announced the appointment of Tom Graney, CFA as Non-Executive Director, Audit Chair and Capital Markets Advisor. He joins...
Rentschler Biopharma has announced the appointment of Dr. Christian Schetter as their new CSO. In this position, Schetter will be working with a...
Stelis Biopharma Limited has announced the appointment of Mark W Womack as the new Chief Executive Officer.
Womack is also the Managing...
Clinical-stage biotherapeutics company PureTech has appointed Julie Krop as Chief Medical Officer.
Krop will oversee all clinical...
Quell Therapeutics has announced the appointment of Tracey Lodie as Chief Scientific Officer.
Dr Lodie brings to Quell more than 20 years...
Cancer research company RareCan has appointed Dr Anita Cooper as Non-Executive Director.
Cooper has over 30 years’ experience in global...
Eli Lilly and Company have announced that Laura Steele has been appointed President and General Manager (GM) for UK, Ireland & Northern Europe...
PrecisionLife Limited has appointed Ray Pawlicki, previously CIO at Biogen and Novartis, as Executive Chair to the board of directors.
...